DUBLIN--(BUSINESS WIRE)--The "Pharmaceuticals Global Group of Eight (G8) Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025).
The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The G8 countries contributed $681.2 billion in 2020 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 4.7% between 2016 and 2020. The G8 countries are expected to reach a value of $788.1 billion in 2025, with a CAGR of 3% over the 2020-25 period.
- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $387.0 billion in 2020. This was followed by Japan and Germany, with a value of $87.0 and $71.3 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $441.0 billion in 2016, followed by Japan and Germany with expected values of $100.9 and $98.5 billion, respectively.
Key Questions Answered:
- What was the size of the G8 pharmaceuticals market by value in 2020?
- What will be the size of the G8 pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the G8 pharmaceuticals market?
Key Benefits:
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
-
Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Key Topics Covered:
1 Introduction
2 Group of Eight (G8) Pharmaceuticals
3 Pharmaceuticals in Canada
4 Pharmaceuticals in France
5 Pharmaceuticals in Germany
6 Pharmaceuticals in Italy
7 Pharmaceuticals in Japan
8 Pharmaceuticals in Russia
9 Pharmaceuticals in The United Kingdom
10 Pharmaceuticals in The United States
11 Company Profiles
- Johnson & Johnson
- Pfizer Inc.
- Apotex, Inc.
- Merck & Co., Inc.
- Sanofi SA
- Laboratoires Pierre Fabre SA
- F. Hoffmann-La Roche Ltd
- Boehringer Ingelheim GmbH
- A Menarini Industrie Farmaceutiche Riunite Srl
- Chiesi Farmaceutici SpA
- Recordati S.p.A.
- Daiichi Sankyo Co Ltd
- Astellas Pharma Inc.
- Mitsubishi Tanabe Pharma Corporation
- Takeda Pharmaceutical Company Limited
- Bayer AG
- Les Laboratoires Servier
- Novartis AG
- GlaxoSmithKline Plc
- AstraZeneca PLC
For more information about this report visit https://www.researchandmarkets.com/r/5epc2j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
